UNM Cancer Center discovers treatment for deadly disorder

News
94193e32715f4b72a7fa29addd12911e_443856

ALBUQUERQUE, N.M. (KRQE) – A new treatment for a deadly immune disorder has been found by researchers at the UNM Comprehensive Cancer Center (UNMCCC).

Mastocytosis, a rare and sometimes deadly immune disorder, is now being treated by a drug called Midostaurin. Midostaurin helps patients with advance Mastocytosis conditions. The most serious type is Leukemia where typically, patients live only about six months after their diagnosis.

Based on a recent clinical trial of Midostaurin, people with advanced Mastocytiosis have lived an average of 28 months longer.

Dr. Tracy George, a researcher at the UNMCCC, and the top American Pathology Expert in Mastocytosis Pathology, joined KRQE’s This Morning team to discuss the study and new drug. Watch above.

The research was recently published in The New England Journal of Medicine, one of the nation’s leading medical journals.

For more information, visit their website.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Video

Now Trending on KRQE.com

New Mexico Hourly Forecasts ⟶

Albuquerque Hourly Forecast

Don't Miss

MORE IN DON'T MISS

Photo Galleries

MORE PHOTO GALLERIES

News Resources - Maps

MORE NEWS RESOURCES